1 Report Overview
1.1 Research Scope
1.2 Top Human Vaccine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Human Vaccine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Varicella
1.3.3 Influenza
1.3.4 Polio
1.3.5 Hepatitis A
1.3.6 Rabies
1.3.7 BCG
1.3.8 Hepatitis B
1.3.9 Pertussis, Diphtheria, Tetanus
1.3.10 Pneumococcal
1.3.11 Rota vaccine
1.4 Market Segment by Application
1.4.1 Global Human Vaccine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Adults
1.4.3 Children
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Human Vaccine Revenue (2015-2026)
2.1.1 Global Human Vaccine Revenue (2015-2026)
2.1.2 Global Human Vaccine Sales (2015-2026)
2.2 Human Vaccine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Human Vaccine Sales by Regions (2015-2020)
2.2.2 Global Human Vaccine Revenue by Regions (2015-2020)
2.3 Global Top Human Vaccine Regions (Countries) Ranking by Market Size
2.4 Human Vaccine Industry Trends
2.4.1 Human Vaccine Market Top Trends
2.4.2 Market Drivers
2.4.3 Human Vaccine Market Challenges
2.4.4 Porter's Five Forces Analysis
2.4.5 Primary Interviews with Key Human Vaccine Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Human Vaccine Manufacturers by Sales (2015-2020)
3.1.1 Global Human Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Human Vaccine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Human Vaccine Sales in 2019
3.2 Global Top Manufacturers Human Vaccine by Revenue
3.2.1 Global Human Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Human Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2019)
3.4 Global Human Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Human Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Human Vaccine Market
3.7 Key Manufacturers Human Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Vaccine Historic Market Review by Type (2015-2020)
4.1.2 Global Human Vaccine Sales Market Share by Type (2015-2020)
4.1.3 Global Human Vaccine Revenue Market Share by Type (2015-2020)
4.1.4 Human Vaccine Price by Type (2015-2020)
4.1 Global Human Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Human Vaccine Sales Forecast by Type (2021-2026)
4.2.3 Global Human Vaccine Revenue Forecast by Type (2021-2026)
4.2.4 Human Vaccine Price Forecast by Type (2021-2026)
5 Global Human Vaccine Market Size by Application
5.1 Global Human Vaccine Historic Market Review by Application (2015-2020)
5.1.2 Global Human Vaccine Sales Market Share by Application (2015-2020)
5.1.3 Global Human Vaccine Revenue Market Share by Application (2015-2020)
5.1.4 Human Vaccine Price by Application (2015-2020)
5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Human Vaccine Sales Forecast by Application (2021-2026)
5.2.3 Global Human Vaccine Revenue Forecast by Application (2021-2026)
5.2.4 Human Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Vaccine Breakdown Data by Company
6.2 North America Human Vaccine Breakdown Data by Type
6.3 North America Human Vaccine Breakdown Data by Application
6.4 North America Human Vaccine Breakdown Data by Countries
6.4.1 North America Human Vaccine Sales by Countries
6.4.2 North America Human Vaccine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Vaccine Breakdown Data by Company
7.2 Europe Human Vaccine Breakdown Data by Type
7.3 Europe Human Vaccine Breakdown Data by Application
7.4 Europe Human Vaccine Breakdown Data by Countries
7.4.1 Europe Human Vaccine Sales by Countries
7.4.2 Europe Human Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Vaccine Breakdown Data by Company
8.2 Asia Pacific Human Vaccine Breakdown Data by Type
8.3 Asia Pacific Human Vaccine Breakdown Data by Application
8.4 Asia Pacific Human Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Human Vaccine Sales by Regions
8.4.2 Asia Pacific Human Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan, China
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Human Vaccine Breakdown Data by Company
9.2 Latin America Human Vaccine Breakdown Data by Type
9.3 Latin America Human Vaccine Breakdown Data by Application
9.4 Latin America Human Vaccine Breakdown Data by Countries
9.4.1 Latin America Human Vaccine Sales by Countries
9.4.2 Latin America Human Vaccine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Vaccine Breakdown Data by Type
10.2 Middle East and Africa Human Vaccine Breakdown Data by Application
10.3 Middle East and Africa Human Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Human Vaccine Sales by Countries
10.3.2 Middle East and Africa Human Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Company 1
11.1.1 Company 1 Corporation Information
11.1.2 Company 1 Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Company 1 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Company 1 Human Vaccine Products and Services
11.1.5 Company 1 SWOT Analysis
11.1.6 Company 1 Recent Developments
11.2 Company 2
11.2.1 Company 2 Corporation Information
11.2.2 Company 2 Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Company 2 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Company 2 Human Vaccine Products and Services
11.2.5 Company 2 SWOT Analysis
11.2.6 Company 2 Recent Developments
11.3 Company 3
11.3.1 Company 3 Corporation Information
11.3.2 Company 3 Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Company 3 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Company 3 Human Vaccine Products and Services
11.3.5 Company 3 SWOT Analysis
11.3.6 Company 3 Recent Developments
11.4 Company 4
11.4.1 Company 4 Corporation Information
11.4.2 Company 4 Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Company 4 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Company 4 Human Vaccine Products and Services
11.4.5 Company 4 SWOT Analysis
11.4.6 Company 4 Recent Developments
11.5 Company 5
11.5.1 Company 5 Corporation Information
11.5.2 Company 5 Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Company 5 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Company 5 Human Vaccine Products and Services
11.5.5 Company 5 SWOT Analysis
11.5.6 Company 5 Recent Developments
11.6 Company 6
11.6.1 Company 6 Corporation Information
11.6.2 Company 6 Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Company 6 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Company 6 Human Vaccine Products and Services
11.6.5 Company 6 SWOT Analysis
11.6.6 Company 6 Recent Developments
11.7 Company 7
11.7.1 Company 7 Corporation Information
11.7.2 Company 7 Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Company 7 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Company 7 Human Vaccine Products and Services
11.7.5 Company 7 SWOT Analysis
11.7.6 Company 7 Recent Developments
11.8 Company 8
11.8.1 Company 8 Corporation Information
11.8.2 Company 8 Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Company 8 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Company 8 Human Vaccine Products and Services
11.8.5 Company 8 SWOT Analysis
11.8.6 Company 8 Recent Developments
全球人類疫苗行業(yè)研究報告，增長趨勢和競爭分析二〇二〇年至2026年
11.9 Company 9
11.9.1 Company 9 Corporation Information
11.9.2 Company 9 Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Company 9 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Company 9 Human Vaccine Products and Services
11.9.5 Company 9 SWOT Analysis
11.9.6 Company 9 Recent Developments
11.10 Company 10
11.10.1 Company 10 Corporation Information
11.10.2 Company 10 Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Company 10 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Company 10 Human Vaccine Products and Services
11.10.5 Company 10 SWOT Analysis
11.10.6 Company 10 Recent Developments
11.11 Company 11
11.11.1 Company 11 Corporation Information
11.11.2 Company 11 Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Company 11 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Company 11 Human Vaccine Products and Services
11.11.5 Company 11 SWOT Analysis
11.11.6 Company 11 Recent Developments
11.12 Company 12
11.12.1 Company 12 Corporation Information
11.12.2 Company 12 Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Company 12 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Company 12 Human Vaccine Products and Services
11.12.5 Company 12 SWOT Analysis
11.12.6 Company 12 Recent Developments
11.13 Company 13
11.13.1 Company 13 Corporation Information
11.13.2 Company 13 Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Company 13 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Company 13 Human Vaccine Products and Services
11.13.5 Company 13 SWOT Analysis
11.13.6 Company 13 Recent Developments
11.14 Company 14
11.14.1 Company 14 Corporation Information
11.14.2 Company 14 Business Overview and Total Revenue (2019 VS 2018)
11.14.3 Company 14 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 Company 14 Human Vaccine Products and Services
11.14.5 Company 14 SWOT Analysis
11.14.6 Company 14 Recent Developments
11.15 Company 15
11.15.1 Company 15 Corporation Information
11.15.2 Company 15 Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Company 15 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Company 15 Human Vaccine Products and Services
11.15.5 Company 15 SWOT Analysis
11.15.6 Company 15 Recent Developments
11.16 Company 16
11.16.1 Company 16 Corporation Information
11.16.2 Company 16 Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Company 16 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Company 16 Human Vaccine Products and Services
11.16.5 Company 16 SWOT Analysis
11.16.6 Company 16 Recent Developments
11.17 Company 17
11.17.1 Company 17 Corporation Information
11.17.2 Company 17 Business Overview and Total Revenue (2019 VS 2018)
11.17.3 Company 17 Human Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 Company 17 Human Vaccine Products and Services
11.17.5 Company 17 SWOT Analysis
11.17.6 Company 17 Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Human Vaccine Sales Channels
12.2.2 Human Vaccine Distributors
12.3 Human Vaccine Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Human Vaccine Sales Forecast (2021-2026)
13.1.1 Global Human Vaccine Sales Forecast by Regions (2021-2026)
13.1.2 Global Human Vaccine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Human Vaccine Sales Forecast (2021-2026)
13.2.2 North America Human Vaccine Revenue Forecast (2021-2026)
13.2.3 North America Human Vaccine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Human Vaccine Sales Forecast (2021-2026)
13.3.2 Europe Human Vaccine Revenue Forecast (2021-2026)
13.3.3 Europe Human Vaccine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Human Vaccine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Human Vaccine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Human Vaccine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Human Vaccine Sales Forecast (2021-2026)
13.5.2 Latin America Human Vaccine Revenue Forecast (2021-2026)
13.5.3 Latin America Human Vaccine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Human Vaccine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Human Vaccine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Human Vaccine Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Human Vaccine Key Market Segments
Table 2. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Vaccine Market Size Growth Rate by Type 2021-2026 (M Doses) & (Million US$)
Table 4. Major Manufacturers of Varicella
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Polio
Table 7. Major Manufacturers of Hepatitis A
Table 8. Major Manufacturers of Rabies
Table 9. Major Manufacturers of BCG
Table 10. Major Manufacturers of Hepatitis B
Table 11. Major Manufacturers of Pertussis, Diphtheria, Tetanus
Table 12. Major Manufacturers of Pneumococcal
Table 13. Major Manufacturers of Rota vaccine
Table 14. Global Human Vaccine Market Share by Application 2019-2025 (M Doses)
Table 15. Global Human Vaccine Market Size by Regions 2015-2020 (M Doses) & (Million US$)
Table 16. Global Human Vaccine Sales by Regions 2015-2020 (M Doses)
Table 17. Global Human Vaccine Sales Market Share by Regions 2015-2020
Table 18. Global Human Vaccine Revenue by Regions 2015-2020 (Million US$)
Table 19. Global Human Vaccine Revenue Market Share by Regions 2015-2020
Table 20. Top Human Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 21. Market Top Trends
全球人類疫苗行業(yè)研究報告，增長趨勢和競爭分析二〇二〇年至2026年
Table 22. Human Vaccine Key Drivers: Impact Analysis (2021-2026)
Table 23. Human Vaccine Key Challenges
Table 24. Main Points Interviewed from Key Human Vaccine Players: Views for Future
Table 25. Global Human Vaccine Sales by Manufacturers (2015-2020) (M Doses)
Table 26. Global Human Vaccine Sales Share by Manufacturers (2015-2020)
Table 27. Human Vaccine Revenue by Manufacturers (2015-2020) (Million US$)
Table 28. Human Vaccine Revenue Share by Manufacturers (2015-2020)
Table 29. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Vaccine as of 2019)
Table 31. Key Manufacturers Human Vaccine Average Selling Price (ASP) (2015-2020) (USD/Dose)
Table 32. Key Manufacturers Human Vaccine Plants/Factories Distribution
Table 33. Key Manufacturers Human Vaccine Area Served
Table 34. Date of Key Manufacturers Enter into Human Vaccine Market
Table 35. Key Manufacturers Human Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Varicella Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 38. Global Influenza Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 39. Global Polio Sales ana Revenue (2015-2020) (M Doses) & (Million US$)
Table 40. Global Hepatitis A Sales ana Revenue (2015-2020) (M Doses) & (Million US$)
Table 41. Global Rabies Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 42. Global BCG Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 43. Global Hepatitis B Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 44. Global Pertussis, Diphtheria, Tetanus Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 45. Global Pneumococcal Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 46. Global Rota vaccine Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 47. Global Human Vaccine Sales (M Doses) by Type (2015-2020)
Table 48. Global Human Vaccine Sales Share by Type (2015-2020)
Table 49. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 50. Global Human Vaccine Price (M Doses) by Type (2015-2020)
Table 51. Global Human Vaccine Sales (M Doses) by Type (2021-2026)
Table 52. Global Human Vaccine Sales Share by Type (2021-2026)
Table 53. Global Human Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 54. Global Human Vaccine Revenue Share by Type (2021-2026)
Table 55. Global Human Vaccine Price (M Doses) by Type (2021-2026)
Table 56. Global Human Vaccine Sales (M Doses) by Application (2015-2020)
Table 57. Global Human Vaccine Sales Share by Application (2015-2020)
Table 58. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 59. Global Human Vaccine Price by Application 2015-2020 (USD/Dose)
Table 60. Global Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 61. Global Human Vaccine Sales Share by Application (2015-2020)
Table 62. Global Human Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 63. Global Human Vaccine Revenue Share by Application (2021-2026)
Table 64. Global Human Vaccine Price (M Doses) by Application (2021-2026)
Table 65. North America Human Vaccine Sales by Company (2015-2020) (M Doses)
Table 66. North America Human Vaccine Sales Market Share by Company (2015-2020)
Table 67. North America Human Vaccine Sales by Type (2015-2020) (M Doses)
Table 68. North America Human Vaccine Sales Market Share by Type (2015-2020)
Table 69. North America Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 70. North America Human Vaccine Sales Market Share by Application (2015-2020)
Table 71. North America Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 72. North America Human Vaccine Sales Market Share by Countries (2015-2020)
Table 73. North America Human Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 74. North America Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 75. Europe Human Vaccine Sales by Company (2015-2020) (M Doses)
Table 76. Europe Human Vaccine Sales Market Share by Company (2015-2020)
Table 77. Europe Human Vaccine Sales by Type (2015-2020) (M Doses)
Table 78. Europe Human Vaccine Sales Market Share by Type (2015-2020)
Table 79. Europe Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 80. Europe Human Vaccine Sales Market Share by Application (2015-2020)
Table 81. Europe Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 82. Europe Human Vaccine Sales Market Share by Countries (2015-2020)
Table 83. Europe Human Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 84. Europe Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 85. Asia Pacific Human Vaccine Sales by Regions (2015-2020) (M Doses)
Table 86. Asia Pacific Human Vaccine Sales Market Share by Regions (2015-2020)
Table 87. Asia Pacific Human Vaccine Sales by Type (2015-2020) (M Doses)
Table 88. Asia Pacific Human Vaccine Sales Market Share by Type (2015-2020)
Table 89. Asia Pacific Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 90. Asia Pacific Human Vaccine Sales Market Share by Application (2015-2020)
Table 91. Asia Pacific Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 92. Asia Pacific Human Vaccine Sales Market Share by Regions (2015-2020)
Table 93. Asia Pacific Human Vaccine Revenue by Regions (2015-2020) (Million US$)
Table 94. Asia Pacific Human Vaccine Revenue Market Share by Regions (2015-2020)
Table 95. Latin America Human Vaccine Sales by Company (2015-2020) (M Doses)
Table 96. Latin America Human Vaccine Sales Market Share by Company (2015-2020)
Table 97. Latin America Human Vaccine Sales by Type (2015-2020) (M Doses)
Table 98. Latin America Human Vaccine Sales Market Share by Type (2015-2020)
Table 99. Latin America Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 100. Latin America Human Vaccine Sales Market Share by Application (2015-2020)
Table 101. Latin America Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 102. Latin America Human Vaccine Sales Market Share by Countries (2015-2020)
Table 103. Latin America Human Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 104. Latin America Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Human Vaccine Sales by Type (2015-2020) (M Doses)
Table 106. Middle East and Africa Human Vaccine Sales Market Share by Type (2015-2020)
Table 107. Middle East and Africa Human Vaccine Sales by Application (2015-2020) (M Doses)
Table 108. Middle East and Africa Human Vaccine Sales Market Share by Application (2015-2020)
Table 109. Middle East and Africa Human Vaccine Sales by Countries (2015-2020) (M Doses)
Table 110. Middle East and Africa Human Vaccine Sales Market Share by Countries (2015-2020)
Table 111. Middle East and Africa Human Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 112. Middle East and Africa Human Vaccine Revenue Market Share by Countries (2015-2020)
Table 113. Company 1 Company Details
Table 114. Company 1 Description and Business Overview
Table 115. Company 1 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Company 1 Human Vaccine Sales Growth Rate (2015-2020)
Table 117. Company 1 Human Vaccine Sales Market Share in Global Market
Table 118. Company 1 Recent Development
Table 119. Company 2 Company Details
Table 120. Company 2 Description and Business Overview
Table 121. Company 2 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Company 2 Human Vaccine Sales Growth Rate (2015-2020)
Table 123. Company 2 Human Vaccine Sales Market Share in Global Market
Table 124. Company 2 Recent Development
Table 125. Company 3 Company Details
Table 126. Company 3 Description and Business Overview
Table 127. Company 3 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Company 3 Human Vaccine Sales Growth Rate (2015-2020)
Table 129. Company 3 Human Vaccine Sales Market Share in Global Market
Table 130. Company 3 Recent Development
Table 131. Company 4 Company Details
Table 132. Company 4 Description and Business Overview
Table 133. Company 4 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 134. Company 4 Human Vaccine Sales Growth Rate (2015-2020)
Table 135. Company 4 Human Vaccine Sales Market Share in Global Market
Table 136. Company 4 Recent Development
Table 137. Company 5 Company Details
Table 138. Company 5 Description and Business Overview
Table 139. Company 5 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 140. Company 5 Human Vaccine Sales Growth Rate (2015-2020)
Table 141. Company 5 Human Vaccine Sales Market Share in Global Market
Table 142. Company 5 Recent Development
Table 143. Company 6 Company Details
quánqiú rénlèi yìmiáo hángyè yán jiù bàogào, zēngzhǎng qūshì hé jìngzhēng fēnxī èr líng èr líng nián zhì 2026 nián
Table 144. Company 6 Description and Business Overview
Table 145. Company 6 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 146. Company 6 Human Vaccine Sales Growth Rate (2015-2020)
Table 147. Company 6 Human Vaccine Sales Market Share in Global Market
Table 148. Company 6 Recent Development
Table 149. Company 7 Company Details
Table 150. Company 7 Description and Business Overview
Table 151. Company 7 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 152. Company 7 Human Vaccine Sales Growth Rate (2015-2020)
Table 153. Company 7 Human Vaccine Sales Market Share in Global Market
Table 154. Company 7 Recent Development
Table 155. Company 8 Company Details
Table 156. Company 8 Description and Business Overview
Table 157. Company 8 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Company 8 Human Vaccine Sales Growth Rate (2015-2020)
Table 159. Company 8 Human Vaccine Sales Market Share in Global Market
Table 160. Company 8 Recent Development
Table 161. Company 9 Company Details
Table 162. Company 9 Description and Business Overview
Table 163. Company 9 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 164. Company 9 Human Vaccine Sales Growth Rate (2015-2020)
Table 165. Company 9 Human Vaccine Sales Market Share in Global Market
Table 166. Company 9 Recent Development
Table 167. Company 10 Company Details
Table 168. Company 10 Description and Business Overview
Table 169. Company 10 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 170. Company 10 Human Vaccine Sales Growth Rate (2015-2020)
Table 171. Company 10 Human Vaccine Sales Market Share in Global Market
Table 172. Company 10 Recent Development
Table 173. Company 11 Company Details
Table 174. Company 11 Description and Business Overview
Table 175. Company 11 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 176. Company 11 Human Vaccine Sales Growth Rate (2015-2020)
Table 177. Company 11 Human Vaccine Sales Market Share in Global Market
Table 178. Company 11 Recent Development
Table 179. Company 12 Company Details
Table 180. Company 12 Description and Business Overview
Table 181. Company 12 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 182. Company 12 Human Vaccine Sales Growth Rate (2015-2020)
Table 183. Company 12 Human Vaccine Sales Market Share in Global Market
Table 184. Company 12 Recent Development
Table 185. Company 13 Company Details
Table 186. Company 13 Description and Business Overview
Table 187. Company 13 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 188. Company 13 Human Vaccine Sales Growth Rate (2015-2020)
Table 189. Company 13 Human Vaccine Sales Market Share in Global Market
Table 190. Company 13 Recent Development
Table 191. Company 14 Company Details
Table 192. Company 14 Description and Business Overview
Table 193. Company 14 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 194. Company 14 Human Vaccine Sales Growth Rate (2015-2020)
Table 195. Company 14 Human Vaccine Sales Market Share in Global Market
Table 196. Company 14 Recent Development
Table 197. Company 15 Company Details
Table 198. Company 15 Description and Business Overview
Table 199. Company 15 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 200. Company 15 Human Vaccine Sales Growth Rate (2015-2020)
Table 201. Company 15 Human Vaccine Sales Market Share in Global Market
Table 202. Company 15 Recent Development
Table 203. Company 16 Company Details
Table 204. Company 16 Description and Business Overview
Table 205. Company 16 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 206. Company 16 Human Vaccine Sales Growth Rate (2015-2020)
Table 207. Company 16 Human Vaccine Sales Market Share in Global Market
Table 208. Company 16 Recent Development
Table 209. Company 17 Company Details
Table 210. Company 17 Description and Business Overview
Table 211. Company 17 Human Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 212. Company 17 Human Vaccine Sales Growth Rate (2015-2020)
Table 213. Company 17 Human Vaccine Sales Market Share in Global Market
Table 214. Company 17 Recent Development
Table 215. Human Vaccine Distributors List
Table 216. Human Vaccine Customers List
Table 217. Global Human Vaccine Sales Forecast 2021-2026 (M Doses) & (Million US$)
Table 218. Global Human Vaccine Sales Forecast by Type 2021-2026 (M Doses)
Table 219. Global Human Vaccine Sales Forecast by Application 2021-2026 (M Doses)
Table 220. Global Human Vaccine Sales Forecast by Regions 2021-2026 (M Doses)
Table 221. Global Human Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 222. North America Human Vaccine Sales Forecast by Countries 2021-2026 (M Doses)
Table 223. North America Human Vaccine Revenue Forecast by Countries 2021-2026
Table 224. Europe Human Vaccine Sales Forecast by Countries 2021-2026 (M Doses)
Table 225. Europe Human Vaccine Revenue Market Share Forecast by Countries 2021-2026
Table 226. Asia Pacific Human Vaccine Sales Forecast by Regions 2021-2026 (M Doses)
Table 227. Asia Pacific Human Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 228. Latin America Human Vaccine Sales Forecast by Countries 2021-2026 (M Doses)
Table 229. Latin America Human Vaccine Revenue Forecast by Countries 2021-2026 (Million US$)
Table 230. Middle East and Africa Human Vaccine Sales Forecast by Regions 2021-2026 (M Doses)
Table 231. Middle East and Africa Human Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Sales Market Shar by Type 2015-2026
Figure 3. Varicella Figures
Figure 4. Influenza Figures
Figure 5. Polio Figures
Figure 6. Hepatitis A Figures
Figure 7. Rabies Figures
Figure 8. BCG Figures
Figure 9. Hepatitis B Figures
Figure 10. Pertussis, Diphtheria, Tetanus Figures
Figure 11. Pneumococcal Figures
Figure 12. Global Human Vaccine Sales Market Share by Application in 2019 & 2026
Figure 13. Adults Use Case
Figure 14. Children Use Case
Figure 15. Human Vaccine Report Years Considered
Figure 16. Global Human Vaccine Market Size 2015-2026 (Million US$)
Figure 17. Global Human Vaccine Sales 2015-2020 (M Doses)
Figure 18. Global Human Vaccine Market Size Market Share by Regions 2015-2020
Figure 19. Global Human Vaccine Sales Market Share by Regions in 2019
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Human Vaccine Sales Share by Manufacturers in 2019
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Vaccine Sales in 2019
Figure 23. Human Vaccine Value Share by Manufacturers in 2019
Figure 24. Human Vaccine Revenue Share by Manufacturers In 2019
Figure 25. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Human Vaccine Revenue Share by Type (2015-2020)
Figure 27. Global Human Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 28. Global Human Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Human Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Human Vaccine Revenue Growth Rate by Application in 2015 & 2019
グローバル人材ワクチン業(yè)界研究報告書、成長動向と競合分析2020-2026
Figure 31. North America Human Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 32. U.S. Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 33. Canada Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 34. Europe Human Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. Germany Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 36. France Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 37. U.K. Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 38. Italy Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 39. Russia Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Asia Pacific Human Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 41. China Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 42. Japan Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 43. South Korea Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 44. India Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 45. Australia Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 46. Taiwan, China Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 47. Indonesia Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 48. Thailand Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Malaysia Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 50. Philippines Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Vietnam Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 52. Latin America Human Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Mexico Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 54. Brazil Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 55. Argentina Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 56. Middle East and Africa Human Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 57. Turkey Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 58. Saudi Arabia Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 59. U.A.E Human Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 60. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Company 12 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Company 13 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Company 14 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Company 15 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Company 16 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Company 17 Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Human Vaccine Value Chain
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. North America Human Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 81. North America Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 82. Europe Human Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 83. Europe Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 84. Asia Pacific Human Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 85. Asia Pacific Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 86. Latin America Human Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 87. Latin America Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 88. Middle East and Africa Human Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 89. Middle East and Africa Human Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
省略………
請撥打：400 612 8668、010-6618 1099、66182099、66183099
Email：KF@Cir.cn 下載《訂購協(xié)議》 ┊ 【網(wǎng)上訂購】 ┊ 了解“訂購流程”
京公網(wǎng)安備 11010802027365號